Clinical Trial Update: Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer [Phase 2]

View source ↗

Summary

This update reports Phase 2 trial results for cabozantinib in women with metastatic hormone-receptor-positive breast cancer. The study status is COMPLETED and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-05-25